Litecoin Just Turned 15. Has It Kept Up With Bitcoin?247 Wallst · Oct 17, 2026
Lite Strategy Marks 15 Years of Litecoin with Launch of "Proof of Time" Public Industry ArchiveGlobeNewsWire · Oct 13, 2026
Stock Traders Purchase High Volume of Lite Strategy Call Options (NASDAQ:LITS)Defense World · Oct 3, 2026
Lite Strategy Reports Fiscal Year 2026 Financial ResultsGlobeNewsWire · Sep 29, 2026
Lite Strategy to Present at the 28th Annual H.C. Wainwright Global Investment Conference in New YorkGlobeNewsWire · Sep 10, 2026
Lite Strategy Repurchases 13% of Outstanding Shares Since December, Increasing Litecoin Backing Per ShareGlobeNewsWire · Jul 30, 2026Lite Strategy, Inc. functions as a clinical-stage pharmaceutical firm, concentrating its efforts on creating innovative and distinct therapeutic solutions for cancer patients. This entity, which was previously known as MEI Pharma, Inc., officially changed its designation to Lite Strategy, Inc. in September 2025. The company was established in 2000 and has its principal operations located in San Diego, California.
| Date | Est. | Actual | |
|---|---|---|---|
| Sep 28, 2026 | -$3.12 | -$0.38 | Beat |
| Feb 17, 2026 | -$3.12 | -$0.82 | Beat |
| Nov 14, 2025 | – | -$0.12 | |
| Sep 29, 2025 | -$1.41 | -$2.76 | Miss |
| May 13, 2025 | – | -$0.39 | |
| Feb 12, 2025 | -$2.20 | -$0.40 | Beat |